Antifungal-resistant Candida species in healthcare settings: a regional public health strategy
Abstract
Antifungal-resistant Candida species have emerged as a significant public health threat in highly interconnected healthcare systems. In recent years, Candida auris and azole-resistant Candida parapsilosis have caused hospital outbreaks associated with high morbidity, mortality and limited therapeutic options, challenging the resilience of healthcare services. Since 2019, and particularly during the COVID-19 pandemic, the Community of Madrid (Spain) has experienced an increase in infections and outbreaks caused by these emerging fungal pathogens, facilitated by intensive care environments, antimicrobial pressure, patient mobility and environmental persistence. In response, the regional public health authorities developed and implemented a comprehensive strategy for the prevention and control of transmission of antifungal-resistant Candida species across all hospitals. This practice-based initiative integrates enhanced epidemiological and microbiological surveillance, early case detection and notification, standardized laboratory identification and antifungal susceptibility testing, molecular typing in outbreak settings, and coordinated infection prevention measures. Key interventions include the systematic use of contact precautions for colonized or infected patients, reinforced hand hygiene, targeted environmental cleaning and disinfection, screening of contacts, and inter-hospital communication supported by a shared surveillance framework. The experience of the Community of Madrid highlights how emerging fungal pathogens challenge health system resilience and underscores the need for coordinated public health responses. Strengthening surveillance systems, laboratory capacity and regional governance is essential to prevent the endemic establishment of antifungal-resistant microorganisms in healthcare settings increasingly affected by global change and healthcare system pressure.
Key messages: • Emerging antifungal-resistant Candida species require integrated surveillance, early detection and coordinated infection prevention measures to reduce transmission in healthcare settings.
• Strengthened public health monitoring, reporting and laboratory capacity are essential for early warning and anticipatory responses to emerging fungal threats.
Related
- “The way I am being treated matters more to me than the TB itself”: experiences of stigma in healthcare settings among people with drug-resistant tuberculosis in Lagos, Nigeria: a qualitative study
- Nanoformulated silymarin enhances antifungal activity against resistant Candida albicans by reducing ergosterol and binding to cell envelope targets
- Global Protective Ventilator Settings Are Not Regional Protection: A Compartment-Resolved Framework for Personalizing Mechanical Ventilation in Acute Respiratory Distress Syndrome
- Improving Antibiotic Stewardship Through a Retrospective Study of the Diagnostic Value of Nasal Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction for Pneumonia in Intensive Care Unit Settings
- Determinants and barriers to mammography screening uptake among Bahraini women: a cross-sectional study in primary healthcare settings
BibTeX
@article{mosquera2026antifungalresistant,
title = {{Antifungal-resistant Candida species in healthcare settings: a regional public health strategy}},
author = {M Mosquera and M Alonso and S Jimenez and A Arce},
journal = {The European Journal of Public Health},
year = {2026},
month = oct,
doi = {10.1093/eurpub/ckag169.1613},
url = {https://doi.org/10.1093/eurpub/ckag169.1613},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Antifungal-resistant Candida species in healthcare settings: a regional public health strategy
AU - M Mosquera
AU - M Alonso
AU - S Jimenez
AU - A Arce
PY - 2026
DA - 2026/10/01
JO - The European Journal of Public Health
DO - 10.1093/eurpub/ckag169.1613
UR - https://doi.org/10.1093/eurpub/ckag169.1613
AB - Antifungal-resistant Candida species have emerged as a significant public health threat in highly interconnected healthcare systems. In recent years, Candida auris and azole-resistant Candida parapsilosis have caused hospital outbreaks associated with high morbidity, mortality and limited therapeutic options, challenging the resilience of healthcare services. Since 2019, and particularly during the COVID-19 pandemic, the Community of Madrid (Spain) has experienced an increase in infections and outbreaks caused by these emerging fungal pathogens, facilitated by intensive care environments, antimicrobial pressure, patient mobility and environmental persistence. In response, the regional public health authorities developed and implemented a comprehensive strategy for the prevention and control of transmission of antifungal-resistant Candida species across all hospitals. This practice-based initiative integrates enhanced epidemiological and microbiological surveillance, early case detection and notification, standardized laboratory identification and antifungal susceptibility testing, molecular typing in outbreak settings, and coordinated infection prevention measures. Key interventions include the systematic use of contact precautions for colonized or infected patients, reinforced hand hygiene, targeted environmental cleaning and disinfection, screening of contacts, and inter-hospital communication supported by a shared surveillance framework. The experience of the Community of Madrid highlights how emerging fungal pathogens challenge health system resilience and underscores the need for coordinated public health responses. Strengthening surveillance systems, laboratory capacity and regional governance is essential to prevent the endemic establishment of antifungal-resistant microorganisms in healthcare settings increasingly affected by global change and healthcare system pressure. Key messages: • Emerging antifungal-resistant Candida species require integrated surveillance, early detection and coordinated infection prevention measures to reduce transmission in healthcare settings. • Strengthened public health monitoring, reporting and laboratory capacity are essential for early warning and anticipatory responses to emerging fungal threats.
SN - 1101-1262
SN - 1464-360X
ER -